FR2824827B1 - Nouveaux derives de 5-phenyl-1h-indole antagoniste des recepteurs de l'interleukine-8 - Google Patents

Nouveaux derives de 5-phenyl-1h-indole antagoniste des recepteurs de l'interleukine-8

Info

Publication number
FR2824827B1
FR2824827B1 FR0106507A FR0106507A FR2824827B1 FR 2824827 B1 FR2824827 B1 FR 2824827B1 FR 0106507 A FR0106507 A FR 0106507A FR 0106507 A FR0106507 A FR 0106507A FR 2824827 B1 FR2824827 B1 FR 2824827B1
Authority
FR
France
Prior art keywords
interleukin
indole
receptors
phenyl
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0106507A
Other languages
English (en)
Other versions
FR2824827A1 (fr
Inventor
Martine Barth
Pierre Dodey
Jean Luc Paquet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratories Fournier SAS
Original Assignee
Laboratories Fournier SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratories Fournier SAS filed Critical Laboratories Fournier SAS
Priority to FR0106507A priority Critical patent/FR2824827B1/fr
Priority to CA002447305A priority patent/CA2447305A1/fr
Priority to US10/477,638 priority patent/US20040138287A1/en
Priority to PCT/FR2002/001649 priority patent/WO2002092567A1/fr
Priority to EP02735543A priority patent/EP1387826A1/fr
Priority to JP2002589453A priority patent/JP2004534033A/ja
Publication of FR2824827A1 publication Critical patent/FR2824827A1/fr
Application granted granted Critical
Publication of FR2824827B1 publication Critical patent/FR2824827B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
FR0106507A 2001-05-17 2001-05-17 Nouveaux derives de 5-phenyl-1h-indole antagoniste des recepteurs de l'interleukine-8 Expired - Fee Related FR2824827B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR0106507A FR2824827B1 (fr) 2001-05-17 2001-05-17 Nouveaux derives de 5-phenyl-1h-indole antagoniste des recepteurs de l'interleukine-8
CA002447305A CA2447305A1 (fr) 2001-05-17 2002-05-16 Nouveaux derives de 5-phenyl-1h-indole antagonistes des recepteurs de l'interleukine-8
US10/477,638 US20040138287A1 (en) 2001-05-17 2002-05-16 Novel 5-phenyl-1h-indole derivatives as antagonists of interleukine-8 receptors
PCT/FR2002/001649 WO2002092567A1 (fr) 2001-05-17 2002-05-16 Nouveaux derives de 5-phenyl-1h-indole antagonistes des recepteurs de l'interleukine-8
EP02735543A EP1387826A1 (fr) 2001-05-17 2002-05-16 Derives de 5-phenyl-1h-indole antagonistes des recepteurs de l'interleukine-8
JP2002589453A JP2004534033A (ja) 2001-05-17 2002-05-16 インターロイキン−８受容体のアンタゴニストとしての新規５−フェニル−１ｈ−インドール誘導体

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0106507A FR2824827B1 (fr) 2001-05-17 2001-05-17 Nouveaux derives de 5-phenyl-1h-indole antagoniste des recepteurs de l'interleukine-8

Publications (2)

Publication Number Publication Date
FR2824827A1 FR2824827A1 (fr) 2002-11-22
FR2824827B1 true FR2824827B1 (fr) 2004-02-13

Family

ID=8863390

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0106507A Expired - Fee Related FR2824827B1 (fr) 2001-05-17 2001-05-17 Nouveaux derives de 5-phenyl-1h-indole antagoniste des recepteurs de l'interleukine-8

Country Status (6)

Country Link
US (1) US20040138287A1 (fr)
EP (1) EP1387826A1 (fr)
JP (1) JP2004534033A (fr)
CA (1) CA2447305A1 (fr)
FR (1) FR2824827B1 (fr)
WO (1) WO2002092567A1 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0124941D0 (en) * 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
GB0124931D0 (en) * 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
GB0124933D0 (en) 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
GB0124934D0 (en) * 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
GB0124936D0 (en) 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
DE60334651D1 (de) 2002-02-12 2010-12-02 Glaxosmithkline Llc Nicotinamide und deren Verwendung als P38 Inhibitoren
GB0217757D0 (en) 2002-07-31 2002-09-11 Glaxo Group Ltd Novel compounds
GB0308185D0 (en) 2003-04-09 2003-05-14 Smithkline Beecham Corp Novel compounds
GB0402138D0 (en) 2004-01-30 2004-03-03 Smithkline Beecham Corp Novel compounds
GB0402143D0 (en) * 2004-01-30 2004-03-03 Smithkline Beecham Corp Novel compounds
GB0402140D0 (en) 2004-01-30 2004-03-03 Smithkline Beecham Corp Novel compounds
GB0512429D0 (en) * 2005-06-17 2005-07-27 Smithkline Beecham Corp Novel compound
PE20070182A1 (es) * 2005-07-29 2007-03-06 Wyeth Corp Derivados cianopirrol-fenil amida como moduladores del receptor de progesterona
PE20070341A1 (es) * 2005-07-29 2007-04-13 Wyeth Corp Derivados de pirrol como moduladores del receptor de progesterona
MX2008002166A (es) * 2005-08-15 2008-04-22 Irm Llc Compuestos y composiciones como mimeticos de trombopoietina (tpo).
KR20120068947A (ko) * 2009-09-24 2012-06-27 에프. 호프만-라 로슈 아게 Ｃｒａｃ 조절제로서의 인돌 유도체
UY38514A (es) 2018-12-17 2020-07-31 Vertex Pharma Inhibidores de apol1 y sus métodos de uso
IL296035A (en) 2020-03-06 2022-10-01 Vertex Pharma Treatment methods for apol-1 dependent focal segmental tuberous sclerosis
WO2021252849A1 (fr) * 2020-06-12 2021-12-16 Vertex Pharmaceuticals Incorporated Inhibiteurs d'apol1 et leur utilisation
TW202227456A (zh) 2020-08-26 2022-07-16 美商維泰克斯製藥公司 Ａｐｏｌ１抑制劑及其使用方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3043849A (en) * 1959-04-20 1962-07-10 Upjohn Co 3-(3-substituted amino-1-propenyl) indoles
JPH10510538A (ja) * 1994-12-13 1998-10-13 スミスクライン・ビーチャム・コーポレイション 新規化合物
US5756507A (en) * 1995-12-14 1998-05-26 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone
US5955492A (en) * 1996-03-28 1999-09-21 Smithkline Beecham Corporation Carboxylic acid indole inhibitors of chemokines

Also Published As

Publication number Publication date
WO2002092567A1 (fr) 2002-11-21
US20040138287A1 (en) 2004-07-15
JP2004534033A (ja) 2004-11-11
CA2447305A1 (fr) 2002-11-21
FR2824827A1 (fr) 2002-11-22
EP1387826A1 (fr) 2004-02-11

Similar Documents

Publication Publication Date Title
FR20C1039I2 (fr) Derives de l'uk-2a
FR2824827B1 (fr) Nouveaux derives de 5-phenyl-1h-indole antagoniste des recepteurs de l'interleukine-8
FR18C1024I1 (fr) Derives d'heterocyclocarboxamide
MA27126A1 (fr) 3'PROMEDICAMENTS DE 2'-DESOXY- β-L-NUCLEOSIDES
MA28393B1 (fr) Dérivés de triazole servant d'antagonistes de la vasopressine
AR028567A1 (es) Nuevos derivados de fenil-propargileter
MA26932A1 (fr) Derives d'imidazole.
AR028596A1 (es) Nuevos derivados de fenilglicina
MA27680A1 (fr) Derives de 4-phenyl-pyridine en tant qu'antagonistes du recepteur de la neurokinine-1
NO20030134L (no) Fremstilling av olefinderivater
MA27083A1 (fr) Derives de nicotine ou d'isonicotine benzothiazole
ATE341537T1 (de) Dolastatin 10 derivate
MA26684A1 (fr) Composes antagonistes de recepteurs de 5-ht4
MA27033A1 (fr) Derives d'acides sulfoniques nouveaux
ATE492535T1 (de) 4-piperidinylalkylamin-derivate, antagonisten von muscarinrezeptoren
DZ3119A1 (fr) Nouveaux dérivés de n-triazolylmethyl-piperazines comme antagonistes des recepteurs de la neurokinine.
MA26941A1 (fr) Nouveaux derives d'aminocyclohexane
PT1322592E (pt) Derivados substituidos de 1-aminobutan-3-ol
DZ3333A1 (fr) Antagonistes de recepteurs d'il-8
AR028607A1 (es) Derivados de 1,4-diazepan-2,5-diona
FR2824826B1 (fr) Nouveaux derives de 5-cyano-1h-indole antagonistes des recepteurs de l'interleukine-8
FR2824092B1 (fr) Ensemble d'elements de construction
MA27240A1 (fr) Derives d'imidazoquinoleine
DE60031450D1 (de) Polymorph v von torasemid
MA25653A1 (fr) Derives d'amides heterocycliques.

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20060131